May 2024
1. EL-MAYET FS, Santos VC, Wijesekera N, Lubbers S, et al
   Glucocorticoid receptor and specificity protein 1 (Sp1) or Sp3, but not the antibiotic Mithramycin A, stimulates human alphaherpesvirus 1 (HSV-1) replication.
   Antiviral Res. 2024;225:105870.
   

   >> Share

   
   November 2023
2. BERNSTEIN DI, Sawtell NM, Bravo FJ, Dixon DA, et al
   Intermittent therapy with helicase-primase inhibitor IM-250 efficiently controls recurrent herpes disease and reduces reactivation of latent HSV.
   Antiviral Res. 2023;219:105733.
   

   >> Share

   
   August 2023
3. GIORGI J, Simon B, Destras G, Semanas Q, et al
   Novel UL23 and UL30 substitutions in HSV1 and HSV2 viruses related to polymorphism or drug resistance.
   Antiviral Res. 2023;216:105672.
   

   >> Share

   
   July 2023
4. FENG Y, Yang Y, Zou S, Qiu S, et al
   Identification of alpha-linolenic acid as a broad-spectrum antiviral against zika, dengue, herpes simplex, influenza virus and SARS-CoV-2 infection.
   Antiviral Res. 2023 Jul 8:105666. doi: 10.1016/j.antiviral.2023.105666.
   

   >> Share

   
   May 2023
5. CIVRA A, Costantino M, Ronchi G, Pontini L, et al
   Identification of oxysterol synthetic analogs as a novel class of late-stage inhibitors of herpes simplex virus 2 replication.
   Antiviral Res. 2023;215:105634.
   

   >> Share

   
   
6. PACHOTA M, Grzywa R, Iwanejko J, Synowiec A, et al
   Novel inhibitors of HSV-1 protease effective in vitro and in vivo.
   Antiviral Res. 2023;213:105604.
   

   >> Share

   
   December 2022
7. SURYAWANSHI RK, Patil CD, Wu D, Panda PK, et al
   Putative targeting by BX795 causes decrease in protein kinase C protein levels and inhibition of HSV1 infection.
   Antiviral Res. 2022;208:105454.
   

   >> Share

   
   November 2022
8. QIN Q, Wang Y, Huang X, Jin X, et al
   SHIP-1 affects herpetic simplex keratitis prognosis by mediating CD4(+) T lymphocytes migration through PI3K signaling and transcription factor KLF2 in the cornea.
   Antiviral Res. 2022;207:105424.
   

   >> Share

   
   October 2022
9. FRASSON I, Solda P, Nadai M, Tassinari M, et al
   Quindoline-derivatives display potent G-quadruplex-mediated antiviral activity against herpes simplex virus 1.
   Antiviral Res. 2022 Oct 10:105432. doi: 10.1016/j.antiviral.2022.105432.
   

   >> Share

   
   May 2022
10. TIAN R, Ju F, Yu M, Liang Z, et al
    A potent neutralizing and protective antibody against a conserved continuous epitope on HSV glycoprotein D.
    Antiviral Res. 2022;201:105298.
    

    >> Share

    
    April 2022
11. ALIMBAROVA L, Egorova A, Riabova O, Monakhova N, et al
    A proof-of-concept study for the efficacy of dispirotripiperazine PDSTP in a rabbit model of herpes simplex epithelial keratitis.
    Antiviral Res. 2022 Apr 26:105327. doi: 10.1016/j.antiviral.2022.105327.
    

    >> Share

    
    March 2022
12. IQBAL A, Suryawanshi R, Yadavalli T, Volety I, et al
    Erratum to "BX795 demonstrates potent antiviral benefits against herpes simplex Virus-1 infection of human cell lines" [Antivir. Res. 80 (2020) 104814].
    Antiviral Res. 2022 Mar 22:105293. doi: 10.1016/j.antiviral.2022.105293.
    

    >> Share

    
    
13. MULLER EE, Maseko DV, Kularatne RS
    Phenotypic and genotypic acyclovir resistance surveillance of genital herpes simplex virus 2 in South Africa.
    Antiviral Res. 2022 Mar 7:105277. doi: 10.1016/j.antiviral.2022.105277.
    

    >> Share

    
    November 2021
14. KONDO H, Koshizuka T, Majima R, Takahashi K, et al
    Characterization of a thiourea derivative that targets viral transactivators of cytomegalovirus and herpes simplex virus type 1.
    Antiviral Res. 2021;196:105207.
    

    >> Share

    
    October 2021
15. UHLIG N, Donner AK, Gege C, Lange F, et al
    Helicase primase inhibitors (HPIs) are efficacious for therapy of human herpes simplex virus (HSV) disease in an infection mouse model.
    Antiviral Res. 2021;195:105190.
    

    >> Share

    
    
16. MADAVARAJU K, Yadavalli T, Singh SK, Qatanani F, et al
    Prophylactic treatment with BX795 blocks activation of AKT and its downstream targets to protect vaginal keratinocytes and vaginal epithelium from HSV-2 infection.
    Antiviral Res. 2021;194:105145.
    

    >> Share

    
    August 2021
17. ROSE R, Brunnemann AK, Baukmann S, Buhler S, et al
    Antiviral susceptibility of recombinant herpes simplex virus 1 strains with specific polymerase amino acid changes.
    Antiviral Res. 2021 Aug 19:105166. doi: 10.1016/j.antiviral.2021.105166.
    

    >> Share

    
    
18. LLORENTE P, Mejias V, Sastre I, Recuero M, et al
    Matrix metalloproteinase 14 regulates HSV-1 infection in neuroblastoma cells.
    Antiviral Res. 2021;192:105116.
    

    >> Share

    
    
19. SCHANG LM, Hu M, Cortes EF, Sun K, et al
    Chromatin-mediated epigenetic regulation of HSV-1 transcription as a potential target in antiviral therapy.
    Antiviral Res. 2021;192:105103.
    

    >> Share

    
    July 2021
20. LIU Y, Tang Q, Rao Z, Fang Y, et al
    Inhibition of herpes simplex virus 1 by cepharanthine via promoting cellular autophagy through up-regulation of STING/TBK1/P62 pathway.
    Antiviral Res. 2021;193:105143.
    

    >> Share

    
    May 2021
21. HARRISON KS, Jones C
    Wnt antagonists suppress herpes simplex virus type 1 productive infection.
    Antiviral Res. 2021 May 4:105082. doi: 10.1016/j.antiviral.2021.105082.
    

    >> Share

    
    March 2021
22. LUGANINI A, Sibille G, Mognetti B, Sainas S, et al
    Effective deploying of a novel DHODH inhibitor against herpes simplex type 1 and type 2 replication.
    Antiviral Res. 2021 Mar 11:105057. doi: 10.1016/j.antiviral.2021.105057.
    

    >> Share

    
    
23. HAGEN NR, Nguyen ML, Williams JD, Bowlin TL, et al
    Pentostatin antagonizes the antiviral activity of MBX-2168 by inhibiting the biosynthesis of the active compound.
    Antiviral Res. 2021;187:105018.
    

    >> Share

    
    February 2021
24. ALVAREZ DM, Duarte LF, Corrales N, Smith PC, et al
    Corrigendum to "Cetylpyridinium chloride blocks herpes simplex virus replication in gingival fibroblasts" [Anti. Res. 179 (2020) 104818].
    Antiviral Res. 2021 Feb 22:105022. doi: 10.1016/j.antiviral.2021.105022.
    

    >> Share

    
    May 2020
25. KIM HC, Oh DS, Park JH, Kim HJ, et al
    Multivalent DNA vaccine protects against genital herpes by T-cell immune induction in vaginal mucosa.
    Antiviral Res. 2020;177:104755.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share